Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Freedman

Showing results (171-180 of 1,513) with videos related to

Pageof 152
Sort By:
Journal of Neuroimmunology|June 12, 2003
Study of Herpesvirus saimiri immortalization of gammadelta T cells derived from peripheral blood and CSF of multiple sclerosis patientsRobert A Pon, Mark S Freedman
Current Treatment Options in Oncology|August 19, 2006
Antibody and immunomodulatory agents in treatment of indolent non-Hodgkin's lymphomaJonathan W Friedberg, Arnold S Freedman
Lancet (London, England)|February 26, 2013
First-line treatment of indolent lymphoma: axing CHOP?Caron A Jacobson, Arnold S Freedman
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1993
Which patients with relapsed non-Hodgkin's lymphoma benefit from high-dose therapy and hematopoietic stem-cell transplantation?A S Freedman, L M Nadler
Psychiatric Services (Washington, D.C.)|April 18, 2023
"Why Won't They Believe Me?"Mark R Munetz, Lois S Freedman
Statistics in Medicine|January 1, 1986
A predictive approach to selecting the size of a clinical trial, based on subjective clinical opinionD J Spiegelhalter, L S Freedman
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|August 1, 1987
Herpes zoster ophthalmicus with delayed cerebral infarction and meningoencephalitisM S Freedman, R D Macdonald
Continuum (Minneapolis, Minn.)|June 5, 2016
Severe, Highly Active, or Aggressive Multiple SclerosisMark S Freedman, Carolina A Rush
Breast Cancer Research and Treatment|March 28, 1998
Meta-analyses of dietary fats and mammary neoplasms in rodent experimentsM P Fay, L S Freedman
Controlled Clinical Trials|December 1, 1989
Comparison of Bayesian with group sequential methods for monitoring clinical trialsL S Freedman, D J Spiegelhalter
Pageof 152

Showing results (171-180 of 1,513) with videos related to

Sort By:
Pageof 152
Journal of Neuroimmunology|June 12, 2003
Study of Herpesvirus saimiri immortalization of gammadelta T cells derived from peripheral blood and CSF of multiple sclerosis patientsRobert A Pon, Mark S Freedman
Current Treatment Options in Oncology|August 19, 2006
Antibody and immunomodulatory agents in treatment of indolent non-Hodgkin's lymphomaJonathan W Friedberg, Arnold S Freedman
Lancet (London, England)|February 26, 2013
First-line treatment of indolent lymphoma: axing CHOP?Caron A Jacobson, Arnold S Freedman
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1993
Which patients with relapsed non-Hodgkin's lymphoma benefit from high-dose therapy and hematopoietic stem-cell transplantation?A S Freedman, L M Nadler
Psychiatric Services (Washington, D.C.)|April 18, 2023
"Why Won't They Believe Me?"Mark R Munetz, Lois S Freedman
Statistics in Medicine|January 1, 1986
A predictive approach to selecting the size of a clinical trial, based on subjective clinical opinionD J Spiegelhalter, L S Freedman
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|August 1, 1987
Herpes zoster ophthalmicus with delayed cerebral infarction and meningoencephalitisM S Freedman, R D Macdonald
Continuum (Minneapolis, Minn.)|June 5, 2016
Severe, Highly Active, or Aggressive Multiple SclerosisMark S Freedman, Carolina A Rush
Breast Cancer Research and Treatment|March 28, 1998
Meta-analyses of dietary fats and mammary neoplasms in rodent experimentsM P Fay, L S Freedman
Controlled Clinical Trials|December 1, 1989
Comparison of Bayesian with group sequential methods for monitoring clinical trialsL S Freedman, D J Spiegelhalter
Pageof 152